NEWS
Making it easy for our investors to stay current with our portfolio companies and their industries.
May 14, 2024
Intensity Therapeutics: A Bargain For A Late-Stage Company With A Remarkable Oncology Drug
April 22, 2024
Rejuvenate Bio to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
April 11, 2024
FDA approves trial of system to measure baby’s oxygen during labour
April 10, 2024
Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
April 10, 2024
Improve Treatment Margins with the Fusion Bx and Unfold AI